BSX - Boston Scientific Corporation (BSX) Q1 2024 Earnings Call Transcript
2024-04-24 11:15:26 ET
Boston Scientific Corporation (BSX)
Q1 2024 Earnings Conference Call
April 24, 2024, 08:00 AM ET
Company Participants
Jon Monson - Senior Vice President, Investor Relations
Mike Mahoney - Chairman and Chief Executive Officer
Dan Brennan - Executive Vice President and Chief Financial Officer
Ken Stein - Chief Medical Officer
Conference Call Participants
Robbie Marcus - JPMorgan
Larry Biegelsen - Wells Fargo
Rick Wise - Stifel
Joanne Wuensch - Citi
Vijay Kumar - Evercore ISI
Travis Steed - Bank of America
Danielle Antalffy - UBS
Josh Jennings - TD Cowen
Chris Pasquale - Nephron Research
Matthew O'Brien - Piper Sandler
Matt Taylor - Jefferies
Matt Miksic - Barclays
Michael Polark - Wolfe Research
Presentation
Operator
Good morning, and welcome to the Boston Scientific First Quarter 2024 Earnings Call. All participants will be in listen-only mode. [Operator Instructions] Please note, this event is being recorded.
I would now like to turn the conference over to Jon Monson, Senior Vice President, Investor Relations. Please go ahead.
Jon Monson
Thank you, Drew, and welcome, everyone, and thanks for joining us today.
With me on today's call are Mike Mahoney, Chairman and Chief Executive Officer, and Dan Brennan, Executive Vice President and Chief Financial Officer.
We issued a press release earlier this morning announcing our Q1 results, which included reconciliations of the non-GAAP measures used in the release. We have posted a link to that release as well as reconciliations of the non-GAAP measures used in today's call to the Investor Relations section of our website under the heading Financials and Filings.
The duration of this morning's call will be approximately one hour. Mike and Dan will provide comments on Q1 performance as well as the outlook for our business, including Q2 and full year 2024 guidance, and then we'll take your questions. During today's Q&A session, Mike and Dan will be joined by our Chief Medical Officer, Dr. Ken Stein....
Boston Scientific Corporation (BSX) Q1 2024 Earnings Call Transcript